Read + Share
Ahn MJ, Bondarenko I, Kalinka E, Cho BC, et al. Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance
Therapy in Metastatic NSCLC: The Phase 2 ORION Study. J Thorac Oncol 2023;18:1594-1606.
PMID: 37390980
|
 |
|
Ahn MJ, Bondarenko I, Kalinka E, Cho BC, et al. Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance
Therapy in Metastatic NSCLC: The Phase 2 ORION Study. J Thorac Oncol 2023;18:1594-1606.
PMID: 37390980
|
|
|
|